Literature DB >> 34266869

Synthetic MRI in Neurofibromatosis Type 1.

G Coban1, S Parlak2, E Gumeler2, H Altunbuker3, B Konuşkan4, J Karakaya5, B Anlar6, K K Oguz2.   

Abstract

BACKGROUND AND
PURPOSE: Synthetic MRI enables the generation of various contrast-weighted images and quantitative data in a reasonable scanning time. We aimed to use synthetic MRI to assess the detection and underlying tissue characteristics of focal areas of signal intensity and normal-appearing brain parenchyma and morphometric alterations in the brains of patients with neurofibromatosis type 1.
MATERIALS AND METHODS: Conventional MR imaging and synthetic MRI were prospectively obtained from 19 patients with neurofibromatosis type 1 and 18 healthy controls. Two neuroradiologists independently evaluated focal areas of signal intensity on both conventional MR imaging and synthetic MRI. Additionally, automatically segmented volume calculations of the brain in both groups and quantitative analysis of myelin, including the focal areas of signal intensity and normal-appearing brain parenchyma, of patients with neurofibromatosis type 1 were performed using synthetic MRI.
RESULTS: The comparison of conventional MR imaging and synthetic MRI showed good correlation in the supratentorial region of the brain (κ = 0.82-1). Automatically segmented brain parenchymal volume, intracranial volume, and GM volumes were significantly increased in the patients with neurofibromatosis type 1 (P < .05). The myelin-correlated compound, myelin fraction volume, WM fraction volume, transverse relaxation rate, and longitudinal relaxation rate values were significantly decreased in focal areas of signal intensity on myelin and WM maps (P < .001); however, GM, GM fraction volume, and proton density values were significantly increased on the GM map (P < .001).
CONCLUSIONS: Synthetic MRI is a potential tool for the assessment of morphometric and tissue alterations as well as the detection of focal areas of signal intensity in patients with neurofibromatosis type 1 in a reasonable scan time.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34266869      PMCID: PMC8423066          DOI: 10.3174/ajnr.A7214

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  30 in total

1.  MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis.

Authors:  S M Said; T L Yeh; R S Greenwood; J K Whitt; L A Tupler; K R Krishnan
Journal:  Neuroreport       Date:  1996-08-12       Impact factor: 1.837

2.  Proton magnetic resonance spectroscopy of brain lesions in children with neurofibromatosis type 1.

Authors:  I D Wilkinson; P D Griffiths; J K Wales
Journal:  Magn Reson Imaging       Date:  2001-10       Impact factor: 2.546

3.  Synthetic MRI of the brain in a clinical setting.

Authors:  I Blystad; J B M Warntjes; O Smedby; A-M Landtblom; P Lundberg; E-M Larsson
Journal:  Acta Radiol       Date:  2012-09-27       Impact factor: 1.990

4.  Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.

Authors:  F Menor; L Marti-Bonmati; E Arana; C Poyatos; H Cortina
Journal:  Eur J Radiol       Date:  1998-01       Impact factor: 3.528

5.  MRI findings in children with neurofibromatosis type 1: a prospective study.

Authors:  S Van Es; K N North; K McHugh; M De Silva
Journal:  Pediatr Radiol       Date:  1996-07

6.  Evolution of white matter lesions in neurofibromatosis type 1: MR findings.

Authors:  R J Sevick; A J Barkovich; M S Edwards; T Koch; B Berg; T Lempert
Journal:  AJR Am J Roentgenol       Date:  1992-07       Impact factor: 3.959

7.  Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging.

Authors:  L Wang; F C Goldstein; E Veledar; A I Levey; J J Lah; C C Meltzer; C A Holder; H Mao
Journal:  AJNR Am J Neuroradiol       Date:  2009-03-11       Impact factor: 3.825

8.  Conventional and synthetic MRI in multiple sclerosis: a comparative study.

Authors:  Wolfgang Krauss; Martin Gunnarsson; Margareta Nilsson; Per Thunberg
Journal:  Eur Radiol       Date:  2017-11-13       Impact factor: 5.315

9.  Alterations in white matter microstructure in neurofibromatosis-1.

Authors:  Katherine H Karlsgodt; Tena Rosser; Evan S Lutkenhoff; Tyrone D Cannon; Alcino Silva; Carrie E Bearden
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis.

Authors:  Laetitia Saccenti; Akifumi Hagiwara; Christina Andica; Kazumasa Yokoyama; Shohei Fujita; Shimpei Kato; Tomoko Maekawa; Koji Kamagata; Alice Le Berre; Masaaki Hori; Akihiko Wada; Ukihide Tateishi; Nobutaka Hattori; Shigeki Aoki
Journal:  Cells       Date:  2020-02-08       Impact factor: 6.600

View more
  1 in total

1.  Synthetic MRI in children with tuberous sclerosis complex.

Authors:  Gokcen Coban; Ekim Gumeler; Safak Parlak; Bahadir Konuskan; Jale Karakaya; Dilek Yalnizoglu; Banu Anlar; Kader K Oguz
Journal:  Insights Imaging       Date:  2022-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.